for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Koninklijke Philips NV

PHG.AS

Latest Trade

31.20EUR

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

30.93

 - 

50.98

As of on the Euronext Amsterdam Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

‍Philips Extends AI-Enabled CT Imaging Portfolio At RSNA 2021​

Nov 29 (Reuters) - Koninklijke Philips NV <PHG.AS>::PHILIPS EXTENDS AI-ENABLED CT IMAGING PORTFOLIO AT RSNA 2021.

Philips Launches New AI-Enabled MR Portfolio At RSNA 2021

Nov 23 (Reuters) - KONINKLIJKE PHILIPS NV <PHG.AS>::TODAY ANNOUNCED NEW AI-ENABLED INNOVATIONS IN MR IMAGING LAUNCHING AT RADIOLOGICAL SOCIETY OF NORTH AMERICA (RSNA) ANNUAL MEETING.DEBUT OF AI-POWERED MR 5300 1.5T SYSTEM, WHICH HAS RECEIVED 510(K) CLEARANCE FROM FDA.REVOLUTIONARY RADIOLOGY WORKFLOW SOLUTION, MR WORKSPACE WITH AI ASSISTANCE, SIMPLIFIES THE PATH FROM IMAGE ACQUISITION TO DIAGNOSIS, EMPOWERING TECHNOLOGISTS TO DRIVE PRODUCTIVITY AND PREDICTABILITY.NEW MR 7700 3.0T SYSTEM WITH MULTINUCLEAR CLINICAL CAPABILITIES IS DESIGNED TO DELIVER HIGHEST QUALITY DIFFUSION IMAGING AND ADVANCED NEUROSCIENCE SEQUENCES.

Philips Integrates MedChat's AI Capabilities For Hospitals

Nov 22 (Reuters) - KONINKLIJKE PHILIPS NV <PHG.AS>::PHILIPS INTEGRATES MEDCHAT4S AI CAPABILITIES TO OPTIMIZE AUTOMATED PATIENT COMMUNICATION AND HOSPITAL WORKFLOWS.HOSPITALS AND OUTPATIENT CLINICS CAN ALSO DIGITALLY NAVIGATE PATIENTS FROM THE TIME AN ORDER IS PLACED, TO WHEN IT IS SCHEDULED AND COMPLETED THROUGH FOLLOW-UP.

Philips Provides Update On Earlier Announced Voluntary Cpap, Bipap And Mechanical Ventilator Recall Notification

Nov 14 (Reuters) - Koninklijke Philips NV <PHG.AS>::PHILIPS PROVIDES UPDATE ON EARLIER ANNOUNCED VOLUNTARY CPAP, BIPAP AND MECHANICAL VENTILATOR RECALL NOTIFICATION.PHILIPS RESPIRONICS INITIATED VOLUNTARY RECALL NOTIFICATION FOR CERTAIN SLEEP & RESPIRATORY CARE PRODUCTS.THE VOLUNTARY RECALL NOTIFICATION WAS INITIATED BY ROYAL PHILIPS SUBSIDIARY, PHILIPS RESPIRONICS ON JUNE 14, 2021.KONINKLIJKE PHILIPS-PHILIPS RESPIRONICS INITIATED VOLUNTARY RECALL NOTIFICATION TO ADDRESS IDENTIFIED POTENTIAL HEALTH RISKS RELATED TO POLYESTER-BASED POLYURETHANE SOUND ABATEMENT FOAM IN DEVICES.REPAIR AND REPLACEMENT PROGRAM IN US AND SEVERAL OTHER MARKETS IS UNDER WAY.SEPARATELY, PHILIPS RESPIRONICS HAS CONDUCTED TESTING TO SUPPORT NEW SILICONE REPLACEMENT FOAM.

Philips Updates On Study About Use Of IVUS In PVD interventions

Nov 8 (Reuters) - Koninklijke Philips NV <PHG.AS>::INTRAVASCULAR ULTRASOUND (IVUS) LINKED WITH IMPROVED HEALTH OUTCOMES IN LARGEST-EVER REAL-WORLD ANALYSIS OF LOWER EXTREMITY PERIPHERAL VASCULAR INTERVENTIONS (PVD).DATA DEMONSTRATE A 32% REDUCTION IN MAJOR ADVERSE LIMB EVENTS, SUCH AS AMPUTATIONS, DURING LOWER EXTREMITY ARTERIAL INTERVENTION.INDEPENDENT ANALYSIS INCLUDES CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS) DATA FROM OVER 700,000 PERIPHERAL ARTERIAL AND PERIPHERAL VENOUS INTERVENTION PATIENTS.THE STUDY, SUPPORTED BY PHILIPS, UNDERLINES THE COMPANY'S COMMITMENT TO A STRONG EVIDENCE BASE FOR ITS INNOVATIONS IN THE PURSUIT OF BETTER PATIENT OUTCOMES, ENHANCED PATIENT AND STAFF EXPERIENCES, AND LOWER COST OF CARE.

Philips Acquires France-Based Medical Technology Company Cardiologs

Nov 8 (Reuters) - Koninklijke Philips NV <PHG.AS>::PHILIPS TO EXPAND ITS CARDIAC DIAGNOSTICS AND MONITORING PORTFOLIO WITH THE ACQUISITION OF CARDIOLOGS.TRANSACTION, WHICH IS SUBJECT TO CUSTOMARY CLOSING CONDITIONS, IS EXPECTED TO BE COMPLETED IN COMING MONTHS.CARDIOLOGS WILL FURTHER STRENGTHEN PHILIPS' CARDIAC MONITORING AND DIAGNOSTICS OFFERING WITH INNOVATIVE SOFTWARE TECHNOLOGY, ELECTROCARDIOGRAM (ECG) ANALYSIS AND REPORTING SERVICES.FINANCIAL DETAILS OF TRANSACTION WERE NOT DISCLOSED.

Philips Announces New Innovations And Clinical Data On Cardiovascular Treatment

Nov 2 (Reuters) - Koninklijke Philips NV <PHG.AS>::TCT 2021: PHILIPS ANNOUNCES NEW INNOVATIONS AND CLINICAL DATA SUPPORTING THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASE.

Philips Q3 Adjusted EBITA Down At 512 Million Euros

Oct 18 (Reuters) - KONINKLIJKE PHILIPS NV <PHG.AS>::PHILIPS DELIVERS Q3 SALES OF EUR 4.2 BILLION, WITH A 7.6% COMPARABLE SALES DECLINE DUE TO HEADWINDS; INCOME FROM CONTINUING OPERATIONS INCREASES TO EUR 442 MILLION, AND ADJUSTED EBITA MARGIN AMOUNTS TO 12.3%.IN Q3 GROUP SALES TOTALED EUR 4.2 BILLION, REFLECTING A 7.6% COMPARABLE SALES DECLINE DUE TO HEADWINDS CAUSED BY GLOBAL SUPPLY CHAIN CHALLENGES AND SLEEP & RESPIRATORY CARE RECALL CONSEQUENCES.Q3 COMPARABLE ORDER INTAKE INCREASED 47%; ORDER INTAKE INCREASED 17% EXCLUDING IMPACT OF A PARTIAL VENTILATOR ORDER CANCELLATION IN Q3 2020.Q3 INCOME FROM CONTINUING OPERATIONS INCREASED TO EUR 442 MILLION, COMPARED TO EUR 279 MILLION IN Q3 2020.Q3 ADJUSTED EBITA OF EUR 512 MILLION, OR 12.3% OF SALES, COMPARED TO EUR 684 MILLION, OR 15.5% OF SALES, IN Q3 2020.WE NOW EXPECT TO DELIVER LOW-SINGLE-DIGIT COMPARABLE SALES GROWTH WITH A MODEST ADJUSTED EBITA MARGIN IMPROVEMENT FOR FULL YEAR 2021.Q3 OPERATING CASH FLOW OF EUR 256 MILLION, COMPARED TO EUR 575 MILLION IN Q3 2020.BASED ON OUR STRONG CUSTOMER DEMAND AND GROWING ORDER BOOK, WE EXPECT TO RESUME OUR GROWTH AND MARGIN EXPANSION TRAJECTORY IN 2022 AS WE WORK THROUGH HEADWINDS.DOMESTIC APPLIANCES DIVESTMENT WAS COMPLETED AS PLANNED, RESULTING IN A EUR 2.5 BILLION GAIN AFTER TAX AND TRANSACTION-RELATED COSTS; REPORTED IN DISCONTINUED OPERATIONS.

Koninklijke Philips Says Clinical Experts Establish First-Ever Global Consensus For Appropriate Use Of Intravascular Ultrasound In Peripheral Vascular Disease Interventions

Oct 5 (Reuters) - Koninklijke Philips NV <PHG.AS>::CLINICAL EXPERTS ESTABLISH FIRST-EVER GLOBAL CONSENSUS FOR APPROPRIATE USE OF INTRAVASCULAR ULTRASOUND (IVUS) IN PERIPHERAL VASCULAR DISEASE INTERVENTIONS.CONSENSUS RESULTS SHARED AT IVUS SYMPOSIUM BY SMITH CENTER OF OUTCOMES RESEARCH DURING VIVA.FIRST GLOBAL ANALYSIS OF IVUS BY INTERVENTIONAL CARDIOLOGY, INTERVENTIONAL RADIOLOGY, AND VASCULAR SURGERY EXPERTS IN PERIPHERAL VASCULAR DISEASE (PVD) INTERVENTIONS.

Philips Announces Five-Year Strategic Partnership With Lankenau Heart Institut

Sept 30 (Reuters) - KONINKLIJKE PHILIPS NV <PHG.AS>::LANKENAU HEART INSTITUTE, PART OF MAIN LINE HEALTH, FIRST IN NORTH AMERICA TO SIGN LONG-TERM STRATEGIC PARTNERSHIP WITH PHILIPS UTILIZING INTEGRATED CARDIOVASCULAR SOLUTIONS.KONINKLIJKE PHILIPS NV - UNIQUE FIVE-YEAR AGREEMENT WILL HELP PHILADELPHIA-BASED HEALTH LEADER INTEGRATE AND STANDARDIZE INNOVATIVE CARDIOVASCULAR CARE, HELPING TO DELIVER ON THE QUADRUPLE AIM.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up